Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.12 USD | -1.85% | +11.58% | -36.34% |
May. 13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
May. 09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 2.180 | 3.330 | 5.450 |
Spread/Res. | -2.75% | -36.34% | -61.10% |
Spread/Supp. | +11.58% | +23.98% | +33.33% |
Support | 1.900 | 1.710 | 1.590 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CHRS Stock
- Charts Coherus BioSciences, Inc.